EN
HI

TRANSGENE BIOTEK Share price

TRABI

HealthcareSmall

4.2

0.18 (4.48%)
Last updated on 16 May, 2025 | 15:22 IST
BUYSELL
Today's High

4.22

Today's Low

4.00

52 Week Low

3.22

52 Week High

10.84

The current prices are delayed, login to your account for live prices

Transgene Biotek Chart

TRANSGENE BIOTEK Share Key Metrics

Volume
47707.00
Market Cap
30.46 CR
LTQ@LTP
6@4.20
ATP
4.19
Var Margin
100 %
Circuit Range
3.82-4.22
Delivery %
0 %
Value
2.00 L
ASM/GSM
No
Market Lot
1

TRANSGENE BIOTEK Futures & Options

Data Not Found

TRANSGENE BIOTEK Corporate Actions

DateAgenda
2025-05-07Audited Results
2025-01-24Quarterly Results
DateEvent TypeAgenda
2025-05-07Board MeetingAudited Results
2025-01-24Board MeetingQuarterly Results

TRANSGENE BIOTEK News

No Data Found

About TRANSGENE BIOTEK

NSE : 0  
BSE : 526139  
ISIN : INE773D01018  

Transgene Biotek Limited incorporated as a Private LimitedCompany on 1st March 1990 was subsequently converted intoPublic Limited on 28th November 1990. The Company isengaged in the research and development and manufacture ofvarious medical reagents both Bio-chemical andImmuno-Diagnostic reagents for the qualitative andquantitative estimation of bio-chemical parameters anddiagnosis of diseases respectivelyMAIN OBJECTS OF THE COMPANYThe main objects of the company as set out in theMemorandum of Association are as under;1. To undertake promote assist or engage in all kinds ofdevelopment work required in the field of Bio-Technologyto develop the entire spectrum of diagnosis by Enzymatic orChemical methods useful in Bio-Chemical assays ELISA andEIA systems and to develop the monitoring equipment fordiagnostic systems.2. To develop manufacture buy sell import export anddeal in all types of vaccines enzyme sensors for medicaland environment applications DNA related products likeimmuno modulators Genetic Engineering in medical and healthsectors antigens of infection agents.3. To set up laboratories develop extract import exportbuy sell deal in hire the technology process methodssystems and to manufacture import export buy sell deal inhire the equipment and instruments chemicals and enzymeswhich are capable of being used in the fields ofBio-Technology genetic engineering and diagnosis.4. To carry on the business of manufacturing producingrefining developing processing or otherwise acquiringbuying selling importing exporting marketing andgenerally dealing in all kinds of drugs medicinespharmaceuticals antibiotics herbal bacteriogical andbiological products chemicals of all kinds laboratoryreagents and other preparations compounds and articlesall kinds of products and by-products arising there fromand in connection there with and all implements substancesapparatus materials and things incidental to or useful inconnection with any of such business.PRESENT BUSINESSThe company has set up facilities for manufacture ofBiochemical and Immuno diagnostic (ELISA Latexagglutination & MIC ) reagents with present aggregateinstalled capacity of 168 lacs tests in Anrich IndustrialEstate Bollarum Medak dist. Andhra Pradesh.

TRANSGENE BIOTEK Management

NamePosition
Dr. K Koteswara Rao Chairman & Managing Director
Mrs. Sujana Kadiam Director
Mrs. Swetha Marri Director
Mr. Santosh Kumar Director
Read More

TRANSGENE BIOTEK FAQs

The Buying Price of TRANSGENE BIOTEK share is 4.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy TRANSGENE BIOTEK share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of TRANSGENE BIOTEK shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio TRANSGENE BIOTEK shares is -4.2. Useful to assess the stock's value relative to its book value.

To assess TRANSGENE BIOTEK’s valuation compare Sector P/E, P/B which are 47.26 & 3.29 with sector averages, along with growth rates and financial metrics.

The Market Cap of TRANSGENE BIOTEK is 30.46 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of TRANSGENE BIOTEK share price is 10.84 & 3.22. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.